Skip to content

Evaluation of the effects of oral nicotine substitutes (1.5mg lozenge) on the craving in moderate smokers placed in non-smoking situations. A randomized, double-blind, placebo-controlled parallel groups trial.

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-506787-13-00
Acronym
V00018PC303
Enrollment
180
Registered
2024-02-07
Start date
2024-04-03
Completion date
2024-05-23
Last updated
2024-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cessation of smoking

Brief summary

Questionnaire of Smoking Urges (QSU)-brief Total score change from baseline at 30 minutes and any earlier times using.

Detailed description

QSU-brief Total score improvement from Baseline., QSU-brief Total score change from baseline at 45, 60 and 90 minutes., Area under curve of QSU-brief Total score improvement from baseline over 30 minutes., • VAS Global evaluation of the craving during the day. • Number of lozenges., Change from baseline Minnesota Nicotine Withdrawal Scale (MNWS) score at the end of Day 1., 5 points Lickert scale., Incidence, severity, causality and outcomes of treatment-emergent adverse events (TEAEs), treatment emergent serious adverse events (TESAEs). Clinically significant abnormalities in physical examinations and vitals signs measurements.

Interventions

DRUGNICOPASS 1
DRUG5 mg SANS SUCRE MENTHE FRAICHEUR
DRUGpastille édulcorée à l'aspartam et à l’acésulfame potassique
DRUGV0018 Placebo

Sponsors

Pierre Fabre Medicament
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Secondary

MeasureTime frame
QSU-brief Total score improvement from Baseline., QSU-brief Total score change from baseline at 45, 60 and 90 minutes., Area under curve of QSU-brief Total score improvement from baseline over 30 minutes., • VAS Global evaluation of the craving during the day. • Number of lozenges., Change from baseline Minnesota Nicotine Withdrawal Scale (MNWS) score at the end of Day 1., 5 points Lickert scale., Incidence, severity, causality and outcomes of treatment-emergent adverse events (TEAEs), treatment emergent serious adverse events (TESAEs). Clinically significant abnormalities in physical examinations and vitals signs measurements.

Primary

MeasureTime frame
Questionnaire of Smoking Urges (QSU)-brief Total score change from baseline at 30 minutes and any earlier times using.

Countries

Bulgaria

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026